ALGN Buyback

Align Technology Announces $200 Million Open Market Repurchase

Published August 05, 2025 at 12:30 PM

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $200 million of Align’s common stock through open market repurchases under Align’s $1.0 billion stock repurchase program that was approved by

Related Questions

Could the repurchase be interpreted as management’s view that the stock is undervalued, and what does that signal about future growth prospects? What is the expected timeline for completing the $200 million repurchase, and does the company have discretion to accelerate or adjust the pace based on market conditions? How does Align’s current buyback program stack up against those of its main competitors in the digital orthodontics and dental device space? Is the $200 million buyback being funded through existing cash reserves or new debt, and what are the balance‑sheet implications? How will the open market repurchase affect the company’s earnings per share (EPS) and valuation multiples? What impact will the $200 million share repurchase have on Align Technology’s stock price in the short term? What influence might the buyback have on the company’s dividend policy and free‑cash‑flow generation moving forward? How does this repurchase compare to Align’s historical share buyback activity and its $1 billion repurchase program?